What is US 7049320 (rolapitant)?
US Patent 7,049,320 is a U.S. patent that includes claims related to rolapitant, an NK1 receptor antagonist used in antiemetic therapy. [1]
Who owns US 7049320 and what does it cover?
To answer ownership and the exact claim scope, you need the patent record details (assignee/applicant and the specific independent claims). Those details are available on the patent page for US 7049320. [1]
When does the US 7,049,320 rolapitant patent expire?
Expiration depends on the patent’s filing/priority dates and whether any extensions or adjustments apply. The patent page for US 7,049,320 is the place to check the legal status and any expiration-related notes. [1]
Is US 7049320 still in force, or has it been invalidated/expired?
You can verify current status (active/expired/terminated, or any litigation outcomes reflected in the record) using the legal status information shown for US 7,049,320. [1]
How is US 7049320 different from other rolapitant patents?
Rolapitant’s patent family typically includes multiple U.S. filings covering different claim themes (for example: compositions, specific intermediates, salts, formulations, or methods). US 7,049,320 will cover the specific subject matter described in its own claims, and comparing it requires reading its claim sections and the related family patents listed in the same database record. [1]
Where can I view the patent text and claims for US 7049320?
You can view the full patent document, including the abstract, description, and claims, on the US patent record page for US 7,049,320. [1]
Sources
[1] https://patents.justia.com/patent/7049320